Skip to Main Content

Paper Details

Identification of potential COVID-19 treatment compounds which inhibit SARS Cov2 prototypic, Delta and Omicron variant infection.
Virology
8
2022
Author NameAffiliation
Sandra P SmieszekVanda Pharmaceuticals Inc.
Bartlomiej PrzychodzenVanda Pharmaceuticals Inc.
  • 1 - 2

Datasets

Release 1.2